Stamford, CT -- (SBWIRE) -- 08/29/2013 -- High Rising Stocks provides investors with the hot penny stock alerts on a regular basis. We will send you alerts through our Free E Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service. Today’s stocks to watch are: InvenSense Inc (NYSE:INVN), OmniVision Technologies, Inc. (NASDAQ:OVTI), Endeavour Silver Corp. (CAN) (NYSE:EXK), Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR)
InvenSense Inc (NYSE:INVN) shares increased 1.62% to $17.57. Investment analysts at Needham & Company began coverage on shares of INVN in a note issued to investors on August 22. The firm set a “buy” rating and a $20.00 price target on the stock.
Additionally, the company on July 30 announced its first quarter fiscal year 2014 results. Net revenue for the first fiscal quarter of 2014 was $55.9 million, up from $39.2 million for the first fiscal quarter of 2013. Net income for the first fiscal quarter of 2014 was $10.3 million, up from $7.7 million for the first fiscal quarter of 2013. Diluted earnings per share for the first fiscal quarter of 2014 was $0.12, up from $0.09 for the first fiscal quarter of 2013.
Is INVN A Strong At The CMP? Get Advantage Of Our Free Trend Analysis Here
OmniVision Technologies, Inc. (NASDAQ:OVTI) shares climbed 2.56% to $18.44. The company on August 1 announced a complete 10.5-megapixel camera solution with a new RGB Clear (RGBC) color filter that delivers exceptional low-light performance.
Additionally, the company will release its financial results for the first quarter of fiscal 2014 following the close of market on Thursday, August 29, 2013. The Company will host a conference call to discuss its financial results at 5:00 p.m. Eastern time on that day.
Is OVTI A Good Buy After The Recent Price Movement? Find Out Here
Endeavour Silver Corp. (CAN) (NYSE:EXK) shares decreased 4.67% to $4.90. The company on August 6 announced its financial results for the Second Quarter, 2013 (reported in US$). For the quarter ended June 30, 2013, the Company generated revenue totaling $71.1 million (2012 - $40.4 million). Adjusted loss was $2.7 million ($0.03 per share) compared to earnings of $5.9 million ($0.07 per share).
Should Investors Rush To Buy EXK After The Solid Rally? Get Special Report Here
Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) shares jumped 3.32% to $5.33. The company on August 22 announced the publication of the findings from the PRISM patient registry in PLOS ONE, an international, peer-reviewed, open-access medical journal. PRISM was the largest registry ever conducted to further understand prevalence and impact of pseudobulbar affect (PBA) in the United States.
Additionally, the company on August 12 said it reached an exclusive agreement to promote pharmaceutical giant Merck & Co.'s type-2 diabetes drug Januvia in long-term care institutional settings in the U.S. Under the accord, Avanir institutional sales force will begin promoting the sitagliptin family of products to health-care practitioners in the long-term care institutional setting in October.
How Should Investors Trade AVNR After The Recent Volatility? Get Free Report Here
High Rising Stocksis always searching the market every day for massive penny stock runs before they happen so you don't have to.We will send you alerts through our Free E Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)